Answers are grounded in this paper and cite their sources.
Long-term assessment of general host immunocompetence of patients with primary malignant brain tumors indicates that although isolated determinations of nonspecific responsiveness are not clinically useful, sequential analyses utilizing a linear combination of in vitro lymphocyte probes are capable of predicting tumor recurrence prior to clinical deterioration.
No takes yet. Share an insight, caveat, or question.
Brooks et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: